Stockholm, May 24, 2023- The Disciplinary Committee of Nasdaq Stockholm AB (the
"Exchange") has found that ISR Immune System Regulation Holding AB (publ)
("ISR" or the "Company") has breached the Nasdaq
The Disciplinary Committee of Nasdaq Stockholm AB (the "Exchange") has found
that ISR Immune System Regulation Holding AB (publ) ("ISR" or the "Company")
has breached the Nasdaq First North Growth Market
On August 31, 2022, ISR Immune System Regulation Holding AB (publ) published
its interim report for the second quarter of 2022 with information on the
company's financial situation. The rules of Nasdaq
ISR is hosting a workshop with a delegation from Bangladesh to prepare for the company s phase I/II clinical trial of the dry powder nasal vaccine for SARS-CoV-2
We are very happy to have two. | June 22, 2022